Biosimilars for management of Crohn disease
Research output: Contribution to journal › Editorial › Research › peer-review
Standard
Biosimilars for management of Crohn disease. / Nielsen, Ole Haagen; Ainsworth, Mark Andrew.
In: Annals of Internal Medicine, Vol. 170, No. 2, 2019, p. 129-130.Research output: Contribution to journal › Editorial › Research › peer-review
Harvard
Nielsen, OH & Ainsworth, MA 2019, 'Biosimilars for management of Crohn disease', Annals of Internal Medicine, vol. 170, no. 2, pp. 129-130. https://doi.org/10.7326/M18-3060
APA
Nielsen, O. H., & Ainsworth, M. A. (2019). Biosimilars for management of Crohn disease. Annals of Internal Medicine, 170(2), 129-130. https://doi.org/10.7326/M18-3060
Vancouver
Nielsen OH, Ainsworth MA. Biosimilars for management of Crohn disease. Annals of Internal Medicine. 2019;170(2):129-130. https://doi.org/10.7326/M18-3060
Author
Bibtex
@article{67cecef003cb44a89e5e12f90fe7e4ac,
title = "Biosimilars for management of Crohn disease",
author = "Nielsen, {Ole Haagen} and Ainsworth, {Mark Andrew}",
year = "2019",
doi = "10.7326/M18-3060",
language = "English",
volume = "170",
pages = "129--130",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "2",
}
RIS
TY - JOUR
T1 - Biosimilars for management of Crohn disease
AU - Nielsen, Ole Haagen
AU - Ainsworth, Mark Andrew
PY - 2019
Y1 - 2019
U2 - 10.7326/M18-3060
DO - 10.7326/M18-3060
M3 - Editorial
C2 - 30535358
AN - SCOPUS:85059991465
VL - 170
SP - 129
EP - 130
JO - Annals of Internal Medicine
JF - Annals of Internal Medicine
SN - 0003-4819
IS - 2
ER -
ID: 218706719